Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
'Yellowstone' made him a fan favorite. His biggest role isn't the one you see. - 2The Best Games On the planet
- 3CVS forecasts 2026 profit above estimates on strong performance
- 4Climate leaders are talking about 'overshoot' into warming danger zone. Here's what it means
- 5Wedding Guest Outraged That Bride and Groom, Who Are in Their 60s and Have Both Been Married Before, Registered for Gifts
- What's The Friendliest City In The United Kingdom?
- Palestinians forced from West Bank refugee camps left in limbo as Israeli demolitions go on
- The most effective method to Remain Ahead in the Most recent Advanced Patterns with a Web based Advertising Degree
- I was about to film a movie with Glen Powell when my hair started falling out in clumps. Alopecia has made me unrecognizable as an actor.
- Nigeria’s return to Windsor castle signals new era in UK economic partnership
- Taylor Swift just released the 'Elizabeth Taylor' music video — but she's not the star of it
- Deadly heat worldwide prompts $300 million for climate health research at COP30
- Hamas urges Hezbollah to kidnap Israeli soldiers in wake of Knesset passing death penalty bill
- Artemis II's moonbound toilet is working again to astronauts' relief after overnight fix
